UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 5.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,121,849 shares of the financial services provider’s stock after selling 114,248 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in CME Group were worth $468,186,000 as of its most recent filing with the SEC.
A number of other hedge funds have also bought and sold shares of CME. Citizens Financial Group Inc. RI increased its position in CME Group by 8.0% during the first quarter. Citizens Financial Group Inc. RI now owns 1,078 shares of the financial services provider’s stock worth $232,000 after acquiring an additional 80 shares during the period. Swedbank AB bought a new position in CME Group in the 1st quarter valued at about $15,017,000. Atria Investments Inc increased its holdings in CME Group by 7.4% in the 1st quarter. Atria Investments Inc now owns 30,295 shares of the financial services provider’s stock valued at $6,522,000 after buying an additional 2,096 shares during the period. Cetera Investment Advisers increased its holdings in CME Group by 429.1% in the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after buying an additional 38,540 shares during the period. Finally, Cetera Advisors LLC increased its holdings in CME Group by 27.8% in the 1st quarter. Cetera Advisors LLC now owns 9,747 shares of the financial services provider’s stock valued at $2,098,000 after buying an additional 2,121 shares during the period. 87.75% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several equities analysts have commented on CME shares. Morgan Stanley raised their target price on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a report on Thursday, October 17th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. TD Cowen started coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price on the stock. Piper Sandler raised their price target on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Finally, Oppenheimer raised their price target on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. According to data from MarketBeat, CME Group currently has a consensus rating of “Hold” and an average target price of $224.47.
Insider Buying and Selling
In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 5.38 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares in the company, valued at $5,587,935.64. This trade represents a 1.57 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,028 shares of company stock worth $1,811,681 in the last ninety days. Company insiders own 0.30% of the company’s stock.
CME Group Stock Up 1.3 %
NASDAQ:CME opened at $237.33 on Friday. The firm’s 50 day simple moving average is $225.05 and its 200 day simple moving average is $211.73. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $238.12. The company has a market cap of $85.52 billion, a PE ratio of 24.96, a P/E/G ratio of 5.29 and a beta of 0.55.
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the company earned $2.25 EPS. The firm’s revenue was up 18.4% compared to the same quarter last year. On average, research analysts anticipate that CME Group Inc. will post 10.22 earnings per share for the current year.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a yield of 1.94%. CME Group’s dividend payout ratio is presently 48.37%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Using the MarketBeat Dividend Tax Calculator
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Buy Cheap Stocks Step by Step
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is the Dogs of the Dow Strategy? Overview and Examples
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.